These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 29238218)

  • 1. Breaking the Cycle, Cholesterol Cycling, and Synapse Damage in Response to Amyloid-β.
    Bate C
    J Exp Neurosci; 2017; 11():1179069517733096. PubMed ID: 29238218
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The cholesterol ester cycle regulates signalling complexes and synapse damage caused by amyloid-β.
    West E; Osborne C; Bate C
    J Cell Sci; 2017 Sep; 130(18):3050-3059. PubMed ID: 28760925
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The phospholipase A
    Osborne C; West E; Bate C
    J Cell Sci; 2018 Apr; 131(8):. PubMed ID: 29588394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monomeric amyloid-β reduced amyloid-β oligomer-induced synapse damage in neuronal cultures.
    Bate C; Williams A
    Neurobiol Dis; 2018 Mar; 111():48-58. PubMed ID: 29272738
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glimepiride protects neurons against amyloid-β-induced synapse damage.
    Osborne C; West E; Nolan W; McHale-Owen H; Williams A; Bate C
    Neuropharmacology; 2016 Feb; 101():225-36. PubMed ID: 26432105
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amyloid-β-induced synapse damage is mediated via cross-linkage of cellular prion proteins.
    Bate C; Williams A
    J Biol Chem; 2011 Nov; 286(44):37955-37963. PubMed ID: 21900234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Monoacylated Cellular Prion Proteins Reduce Amyloid-β-Induced Activation of Cytoplasmic Phospholipase A2 and Synapse Damage.
    West E; Osborne C; Nolan W; Bate C
    Biology (Basel); 2015 Jun; 4(2):367-82. PubMed ID: 26043272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cholesterol ester hydrolase inhibitors reduce the production of synaptotoxic amyloid-β oligomers.
    McHale-Owen H; Bate C
    Biochim Biophys Acta Mol Basis Dis; 2018 Mar; 1864(3):649-659. PubMed ID: 29247837
    [TBL] [Abstract][Full Text] [Related]  

  • 9. An in vitro model for synaptic loss in neurodegenerative diseases suggests a neuroprotective role for valproic acid via inhibition of cPLA2 dependent signalling.
    Williams RS; Bate C
    Neuropharmacology; 2016 Feb; 101():566-75. PubMed ID: 26116815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Amyloid-β(1-40) inhibits amyloid-β(1-42) induced activation of cytoplasmic phospholipase A2 and synapse degeneration.
    Bate C; Williams A
    J Alzheimers Dis; 2010; 21(3):985-93. PubMed ID: 20634578
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Platelet-activating factor antagonists enhance intracellular degradation of amyloid-β42 in neurons via regulation of cholesterol ester hydrolases.
    Simmons C; Ingham V; Williams A; Bate C
    Alzheimers Res Ther; 2014; 6(2):15. PubMed ID: 24625058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sialylated glycosylphosphatidylinositols suppress the production of toxic amyloid-β oligomers.
    Nolan W; McHale-Owen H; Bate C
    Biochem J; 2017 Aug; 474(17):3045-3058. PubMed ID: 28729427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Valproic acid and its congener propylisopropylacetic acid reduced the amount of soluble amyloid-β oligomers released from 7PA2 cells.
    Williams RSB; Bate C
    Neuropharmacology; 2018 Jan; 128():54-62. PubMed ID: 28947378
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prion protein-mediated toxicity of amyloid-β oligomers requires lipid rafts and the transmembrane LRP1.
    Rushworth JV; Griffiths HH; Watt NT; Hooper NM
    J Biol Chem; 2013 Mar; 288(13):8935-51. PubMed ID: 23386614
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clustering of sialylated glycosylphosphatidylinositol anchors mediates PrP-induced activation of cytoplasmic phospholipase A 2 and synapse damage.
    Bate C; Williams A
    Prion; 2012; 6(4):350-3. PubMed ID: 22895089
    [TBL] [Abstract][Full Text] [Related]  

  • 16. α-Synuclein-induced synapse damage in cultured neurons is mediated by cholesterol-sensitive activation of cytoplasmic phospholipase A2.
    Bate C; Williams A
    Biomolecules; 2015 Mar; 5(1):178-93. PubMed ID: 25761116
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytosolic phospholipase A2 mediates neuronal apoptosis induced by soluble oligomers of the amyloid-beta peptide.
    Kriem B; Sponne I; Fifre A; Malaplate-Armand C; Lozac'h-Pillot K; Koziel V; Yen-Potin FT; Bihain B; Oster T; Olivier JL; Pillot T
    FASEB J; 2005 Jan; 19(1):85-7. PubMed ID: 15486059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The role of cytosolic phospholipase A2 α in amyloid precursor protein induction by amyloid beta1-42 : implication for neurodegeneration.
    Sagy-Bross C; Kasianov K; Solomonov Y; Braiman A; Friedman A; Hadad N; Levy R
    J Neurochem; 2015 Mar; 132(5):559-71. PubMed ID: 25533654
    [TBL] [Abstract][Full Text] [Related]  

  • 19. cAMP-Inhibits Cytoplasmic Phospholipase A₂ and Protects Neurons against Amyloid-β-Induced Synapse Damage.
    Bate C; Williams A
    Biology (Basel); 2015 Sep; 4(3):591-606. PubMed ID: 26389963
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of cytosolic Phospholipase A2 prevents prion peptide-induced neuronal damage and co-localisation with Beta III Tubulin.
    Last V; Williams A; Werling D
    BMC Neurosci; 2012 Aug; 13():106. PubMed ID: 22928663
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.